Answers are grounded in this paper and cite their sources.
Background: The use of biomarkers may significantly predict the need for special care and mortality risk in patients with COVID-19. Objectives: This study examines the glutathione redox status, inflammatory markers, and vitamin D levels in hospitalized COVID-19 patients in the intensive care unit (ICU). Methods: A cohort of COVID-19 patients (n = 16) was compared to a healthy control group. Levels of reduced glutathione (GSH), oxidized glutathione (GSSG), C-reactive protein (CRP), interleukin-10 (IL-10), interleukin-6 (IL-6), cysteine, cystine, and vitamin D were measured using enzyme-linked immunosorbent assay (ELISA). Independent t-tests and Cohen's d were employed to analyze differences. Results: COVID-19 patients exhibited significant differences from healthy controls in all measured indicators, including GSH, GSSG, CRP, IL-10, IL-6, cysteine, cystine, and the GSH/GSSG ratio (P ≤ 0.001). Additionally, all patients demonstrated vitamin D deficiency, with levels ranging from 10 to 20 ng/dL. Ratios of GSH to GSSG, IL-6 to IL-10, and CRP to cysteine also indicated significant differences between COVID-19 patients and healthy controls (P ≤ 0.001). Conclusions: Measurement of glutathione redox indicators, IL-6 and IL-10 levels, and their respective ratios, along with vitamin D and cysteine/cystine levels, could serve as effective predictors for timely interventions in COVID-19 patients hospitalized in the ICU.
No takes yet. Share an insight, caveat, or question.
Skishahr et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: